MyHealthChecked PLC provided revenue guidance for the full year 2023. Revenue for the full year amounted to approximately £11 million (first half: £2.5 million, 2022 fiscal year: £22.3 million) due to the increased seasonal demand for COVID lateral flow tests (LFTs) during H2 which continue to account for the majority of revenue.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.681 GBX | -3.19% | -3.19% | -26.94% |
Jan. 11 | MyHealthChecked expects 2023 earnings breakeven | AN |
Jan. 11 | MyHealthChecked PLC Provides Revenue Guidance for the Full Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.94% | 6.53M | |
+11.25% | 225B | |
+10.04% | 186B | |
+13.19% | 135B | |
+25.55% | 107B | |
+0.80% | 63.56B | |
+5.62% | 51.32B | |
+12.92% | 51.04B | |
+7.26% | 43.3B | |
+4.63% | 36.99B |
- Stock Market
- Equities
- FRI Stock
- News MyHealthChecked PLC
- MyHealthChecked PLC Provides Revenue Guidance for the Full Year 2023